2004
DOI: 10.1074/jbc.m400407200
|View full text |Cite
|
Sign up to set email alerts
|

Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
93
0
1

Year Published

2005
2005
2013
2013

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 138 publications
(106 citation statements)
references
References 54 publications
10
93
0
1
Order By: Relevance
“…Two other Notch target genes, NRARP and Deltex-1 were shown to be potent negative regulators of Notch signaling [23,24]. Furthermore, Notch target genes implicated in cancer are c-myc [16,25,26], cyclinD1 [27] and p21/Waf1 [28]. Other Notch target genes are NFkB2 [29], Ifi-202, Ifi-204, Ifi-D3, and ADAM19 [19].…”
Section: Notch Target Genesmentioning
confidence: 99%
“…Two other Notch target genes, NRARP and Deltex-1 were shown to be potent negative regulators of Notch signaling [23,24]. Furthermore, Notch target genes implicated in cancer are c-myc [16,25,26], cyclinD1 [27] and p21/Waf1 [28]. Other Notch target genes are NFkB2 [29], Ifi-202, Ifi-204, Ifi-D3, and ADAM19 [19].…”
Section: Notch Target Genesmentioning
confidence: 99%
“…Specifically, retroviral transduction of MLL-ENL into wild type or Hoxa9 À/À primary myeloid progenitors revealed the necessity of Hoxa9 in MLL-ENL-mediated leukemogenesis . Moreover, MLL-ENL immortalization of myeloid progenitor cells could be substituted for by overexpression of HoxA9 and Meis1 (Zeisig et al, 2004), and was dependent on the activity of the oncoprotein c-Myc (Schreiner et al, 2001), a downstream effector of Hoxb4 that is sufficient to induce HSC self-renewal (Satoh et al, 2004). By contrast, analogous studies in a germline mouse model of Mll-AF9-mediated leukemogenesis suggest that Hoxa9 is not necessary for leukemia but does influence the phenotype of the leukemia (Kumar et al, 2004).…”
Section: Mll Fusion Genesmentioning
confidence: 99%
“…Many factors that regulate cell-cycle progression are mutated in cancer resulting in deregulated cellular growth. It has been demonstrated that Notch is involved in driving cell-cycle progression by regulating genes involved in the G 1 to S-phase transition (Ronchini and Capobianco, 2000;Satoh et al, 2004;Murata et al, 2005;Sharma et al, 2006;Weng et al, 2006). Notch directly regulates D-type cyclins, which, in conjunction with cyclin-dependent kinase (cdk) 4 and cdk6 facilitate progression through the G 1 phase (Ronchini and Capobianco, 2000).…”
Section: Notch Regulates Cell-cycle Progressionmentioning
confidence: 99%
“…Notch induces cell-cycle progression also through direct transactivation of c-myc (Satoh et al, 2004;Sharma et al, 2006;Weng et al, 2006). Normally, c-myc is only expressed in dividing cells and induces cell-cycle progression through induction of D-type cyclins, cyclin E, cdk4 and cdc25A, as well as repression of p27 expression (reviewed in Amati et al, 1998).…”
Section: Notch Regulates Cell-cycle Progressionmentioning
confidence: 99%